On top of recently winning an EphMRA award, we’re delighted to support the growth of our global team by announcing some well-deserved promotions.
Roy excels in building very successful and long-lasting client relationships and will be taking a leading role in looking for innovative ways to help our pharma and healthcare clients grow. In addition, his knowledge and leadership in technical quant will help us further define our integrated qual/quant offer to clients.
Lucy continually innovates, taking the lead on how Hall & Partners brings big data to health. The demonstrable advancements she has made to our quant offering will ensure we continue to offer clients integrated solutions that meet all their business needs. Lucy’s passionate and determined approach make her a strong addition to our leadership team.
Laura always gets to grips with the content on every project and provides sharp and focused answers to our clients' business questions, leading to many requests for her involvement on new projects. She has demonstrated her smart thinking across a wide range of therapeutic areas and clients, with a particular emphasis on oncology and auto-immune.
Jordan rises to new challenges, combining her natural interest in broader pharma issues with a keen focus on the business implications for our clients. Her versatile approach sees her working comfortably across qual and quant methodologies and many types of project, from detailed project planning to strategic thinking.
Through her sheer determination, phenomenal organization and charming demeanor, Sara has won the hearts of clients and colleagues alike. She has played a major role in growing several of Hall & Partners’ most high-profile pharma accounts alongside championing internal initiatives around better quant data display to enhance client management.